Filtros de búsqueda

Lista de obras de Sergio Amadori

A Leukemia-Associated CD34/CD123/CD25/CD99+ Immunophenotype Identifies FLT3-Mutated Clones in Acute Myeloid Leukemia.

artículo científico publicado en 2015

A cluster of Geotrichum clavatum (Saprochaete clavata) infection in haematological patients: a first Italian report and review of literature.

artículo científico publicado en 2016

A microgranular variant of acute promyelocytic leukemia with atypical morpho-cytochemical features and an early myeloid immunophenotype

artículo científico publicado en 1997

A new system for quality control in hematopoietic progenitor cell units before reinfusion in autologous transplant.

artículo científico publicado en 2013

A novel t(11;12)(q23-24;q24) in a case of minimally-differentiated acute myeloid leukemia (AML-M0).

artículo científico publicado en 2000

A one-mutation mathematical model can explain the age incidence of acute myeloid leukemia with mutated nucleophosmin (NPM1).

artículo científico publicado en 2008

A prospective study comparing quantitative Cytomegalovirus (CMV) polymerase chain reaction in plasma and pp65 antigenemia assay in monitoring patients after allogeneic stem cell transplantation

artículo científico publicado en 2006

A randomized study of the efficacy of postconsolidation therapy in adult acute nonlymphocytic leukemia: a report of the Italian Cooperative Group GIMEMA

scientific article published on 01 April 1992

A simple prognostic scoring system for newly diagnosed cytogenetically normal acute myeloid leukemia: retrospective analysis of 530 patients

artículo científico publicado en 2011

AIDA 0493 protocol for newly diagnosed acute promyelocytic leukemia: very long-term results and role of maintenance

artículo científico publicado en 2011

Activity and safety profile of low-dose rituximab for the treatment of autoimmune cytopenias in adults

artículo científico publicado en 2007

Advances in the treatment of elderly and frail patients with acute myeloid leukemia.

artículo científico publicado en 2014

Alternative novel therapies for the treatment of elderly acute myeloid leukemia patients.

artículo científico

Amount of spontaneous apoptosis detected by Bax/Bcl-2 ratio predicts outcome in acute myeloid leukemia (AML).

artículo científico publicado en 2002

An allele-specific rt-PCR assay to detect type A mutation of the nucleophosmin-1 gene in acute myeloid leukemia.

artículo científico publicado en 2008

Autologous stem cell transplantation after complete remission and first consolidation in acute myeloid leukemia patients aged 61-70 years: results of the prospective EORTC-GIMEMA AML-13 study

scientific article published on 01 March 2007

Automated haematology analysers in acute and chronic leukaemias

scientific article published on 01 January 1998

Biologic aspects of thrombopoietin and the development of novel thrombopoietic agents for clinical use.

artículo científico publicado en 2007

Biological monitoring of Italian soldiers deployed in Iraq. Results of the SIGNUM project

artículo científico publicado en 2015

Bisantrene in relapsed and refractory acute myelogenous leukemia.

artículo científico publicado en 1993

Blast cell kinetics and prognosis in acute nonlymphocytic leukemia

artículo científico publicado en 1980

Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study.

artículo científico publicado en 2012

Bortezomib: efficacy comparisons in solid tumors and hematologic malignancies.

artículo científico publicado en 2006

CD69 is independently prognostic in chronic lymphocytic leukemia: a comprehensive clinical and biological profiling study.

artículo científico publicado en 2011

CD90/Thy-1 is preferentially expressed on blast cells of high risk acute myeloid leukaemias

artículo científico publicado en 2004

CNS and cutaneous involvement in patients with chronic myeloid leukemia treated with imatinib in hematologic complete remission: two case reports

artículo científico publicado en 2003

Cancer-related fatigue: evolving concepts in evaluation and treatment.

artículo científico publicado en 2003

Central nervous system involvement in adult acute lymphoblastic leukemia: diagnostic tools, prophylaxis, and therapy.

artículo científico publicado en 2014

Centre effect on treatment outcome for patients with untreated acute myelogenous leukaemia? An analysis of the AML 8A Study of the Leukemia Cooperative Group of the EORTC and GIMEMA. European Organization for Research and Treatment of Cancer (EORTC)

artículo científico publicado en 1999

Chromosomal aberration of the 11q23 locus in acute leukemia and frequency of MLL gene translocation: results in 378 adult patients

scientific article published on 01 August 2004

Clinical and biological impact of TET2 mutations and expression in younger adult AML patients treated within the EORTC/GIMEMA AML-12 clinical trial

artículo científico publicado en 2014

Clinical relevance of minimal residual disease detection in adult acute myeloid leukemia

scientific article published on 01 April 2002

Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemia

artículo científico publicado en 2006

Clinical significance of bax/bcl-2 ratio in chronic lymphocytic leukemia

artículo científico publicado en 2015

Clinical significance of c.7544-7545 delCT NOTCH1 mutation in chronic lymphocytic leukaemia

artículo científico publicado en 2012

Clinicopathologic characterization of diffuse-large-B-cell lymphoma with an associated serum monoclonal IgM component

artículo científico publicado en 2014

Clofarabine in combination with a standard remission induction regimen (cytosine arabinoside and idarubicin) in patients with previously untreated intermediate and bad-risk acute myelogenous leukemia (AML) or high-risk myelodysplastic syndrome (HR-M

artículo científico publicado en 2014

Collection of peripheral progenitor cells: a comparison between Amicus and Cobe-Spectra blood cell separators

scientific article published on 01 April 2004

Comparative molecular analysis of therapy-related and de novo acute promyelocytic leukemia.

artículo científico publicado en 2011

Comparison between conventional banding analysis and FISH screening with an AML-specific set of probes in 260 patients

scientific article published on 01 January 2003

Comparison of rHuEpo plus rHuG-CSF and supportive care: apples to oranges

artículo científico publicado en 2004

Complete regression of cutaneous lesions of refractory Ph+ ALL after 4 weeks of treatment with BMS-354825

scientific article published on 01 June 2006

Consolidation and maintenance immunotherapy with rituximab improve clinical outcome in patients with B-cell chronic lymphocytic leukemia.

artículo científico publicado en 2008

Continuous low-dose subcutaneous desferrioxamine (DFO) to prevent allergic manifestations in patients with iron overload

scientific article published on 01 December 1996

Cryopreserved autologous bone marrow infusion following high dose chemotherapy in patients with acute myeloblastic leukemia in first relapse

artículo científico publicado en 1985

Cytogenetic analysis is non-informative for assessing the remission rate in chronic myeloid leukemia (CML) patients on interferon-alpha (IFN-alpha) therapy

scientific article published on 01 October 1995

Cytogenetic and molecular diagnostic characterization combined to postconsolidation minimal residual disease assessment by flow cytometry improves risk stratification in adult acute myeloid leukemia

artículo científico publicado en 2010

Dasatinib induces significant hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in accelerated phase

article

Daunomycin, cytosine arabinoside and 6-thioguanine (DAT) vs vincristine, cytosine arabinoside and 6-thioguanine (VAT) in the induction treatment of acute nonlymphocytic leukemia: A randomized collaborative study ⬇️

artículo científico publicado el 1 de enero de 1978

Daunorubicin, cytosine arabinoside and 6-thioguanine (DAT) combination chemotherapy for the treatment of acute non-lymphocytic leukemia

artículo científico publicado el 1 de enero de 1979

Deregulation of the mitochondrial apoptotic machinery and development of molecular targeted drugs in acute myeloid leukemia.

artículo científico publicado en 2008

Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia

artículo científico publicado en 2010

Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel

artículo científico publicado en 2016

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

artículo científico publicado en 2009

Diagnosis of acute foetal distress does not preclude banking of umbilical cord blood units

artículo científico publicado en 2006

Diagnostic refinement of chronic myeloproliferative disorders and thrombocytoses of unknown origin by multiple RT-PCR and capillary electrophoresis of BCR-ABL rearrangements and JAK2 (V617F) mutation

scientific article published on 07 February 2007

Effect of a p210 multipeptide vaccine associated with imatinib or interferon in patients with chronic myeloid leukaemia and persistent residual disease: a multicentre observational trial

artículo científico publicado en 2005

Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic review

artículo científico publicado en 2008

Enhancement of anti-leukemia activity of NK cells in vitro and in vivo by inhibition of leukemia cell-induced NK cell damage

artículo científico publicado en 2015

Enhancing the effectiveness of nucleoside analogs with mTORC1 blockers to treat acute myeloid leukemia patients

artículo científico publicado en 2013

Epstein-Barr virus-positive lymphoma after alemtuzumab therapy for B-cell chronic lymphocytic leukemia.

artículo científico publicado en 2009

Etoposide, intermediate-dose cytarabine and carboplatin (VAC): a combination therapy for the blastic phase of chronic myelogenous leukemia

artículo científico publicado en 1997

Evaluation of the prognostic relevance of L-selectin and ICAM1 expression in myelodysplastic syndromes

scientific article published on 17 November 2007

Extensive toxic epidermal necrolysis following brentuximab vedotin administration

article

FISH analysis for CML monitoring?

scientific article published on 01 September 1996

Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice

artículo científico publicado en 2004

Fluorescence in situ hybridization and conventional cytogenetics for the diagnosis of 11q23+/MLL+ translocation in leukaemia

scientific article published on 01 June 2003

Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation for adults younger than 61 years: results of the AIDA-2000 trial of the GIMEMA Group

artículo científico publicado en 2010

Fulminant B hepatitis in a surface antigen-negative patient with B-cell chronic lymphocytic leukaemia after rituximab therapy

artículo científico publicado en 2005

GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia

artículo científico publicado en 2019

Gemtuzumab Ozogamicin Versus Best Supportive Care in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Unsuitable for Intensive Chemotherapy: Results of the Randomized Phase III EORTC-GIMEMA AML-19 Trial

artículo científico publicado en 2016

Gemtuzumab ozogamicin (Mylotarg) as single-agent treatment for frail patients 61 years of age and older with acute myeloid leukemia: final results of AML-15B, a phase 2 study of the European Organisation for Research and Treatment of Cancer and Grup

scientific article published on 01 October 2005

Gemtuzumab ozogamicin in the treatment of acute myeloid leukemia

artículo científico publicado en 2007

Helicobacter pylori eradication in the management of patients with idiopathic thrombocytopenic purpura

artículo científico publicado en 2005

Heterogeneity in the therapeutic approach to relapsed elderly patients with acute myeloid leukaemia: a survey from the Gruppo Italiano Malattie Ematologiche dell' Adulto (GIMEMA) Acute Leukaemia Working Party.

artículo científico publicado en 2008

High numbers of mobilized CD34+ cells collected in AML in first remission are associated with high relapse risk irrespective of treatment with autologous peripheral blood SCT or autologous BMT.

artículo científico publicado en 2014

High sensitivity of flow cytometry improves detection of occult leptomeningeal disease in acute lymphoblastic leukemia and lymphoblastic lymphoma

artículo científico publicado en 2014

High-dose chemotherapy in adult acute myeloid leukemia: rationale and results.

artículo científico publicado en 1996

High-dose cytarabine in induction treatment improves the outcome of adult patients younger than age 46 years with acute myeloid leukemia: results of the EORTC-GIMEMA AML-12 trial

artículo científico publicado en 2013

High-dose epoetin alfa as induction treatment for severe anemia in multiple myeloma patients

artículo científico publicado en 2009

Hodgkin lymphoma in a mutated ZAP-70 negative B-cell Chronic Lymphocytic Leukemia patient

scientific article published on 20 April 2007

Hydroxyurea therapy in paraparesis and cauda equina syndrome due to extramedullary haematopoiesis in thalassaemia: improvement of clinical and haematological parameters

artículo científico publicado en 2000

IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: a GIMEMA AL WP report

artículo científico publicado en 2009

Idarubicin and cytarabine in combination with gemtuzumab ozogamicin (IAGO) for untreated patients with high-risk MDS or AML evolved from MDS: a phase II study from the EORTC and GIMEMA Leukemia Groups (protocol 06013).

artículo científico publicado en 2015

Identification of emerging FLT3 ITD-positive clones during clinical remission and kinetics of disease relapse in acute myeloid leukaemia with mutated nucleophosmin.

artículo científico publicado en 2013

Idiopathic thrombocytopenic purpura: current concepts in pathophysiology and management

artículo científico publicado en 2008

Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemia

scientific article published on 23 May 2006

Impact of NPM1/FLT3-ITD genotypes defined by the 2017 European LeukemiaNet in patients with acute myeloid leukemia

artículo científico publicado en 2020

Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non-High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial.

artículo científico publicado en 2016

Induction therapy with idarubicin alone significantly influences event-free survival duration in patients with newly diagnosed hypergranular acute promyelocytic leukemia: final results of the GIMEMA randomized study LAP 0389 with 7 years of minimal

artículo científico publicado en 2002

Infections increase the risk of central venous catheter-related thrombosis in adult acute myeloid leukemia

artículo científico publicado en 2013

Infliximab chimeric antitumor necrosis factor-a monoclonal antibody as potential treatment for myelodysplastic syndromes.

artículo científico publicado en 2005

Integration of monoclonal antibodies and immunoconjugates into the treatment of acute myeloid leukemia.

artículo científico publicado en 2008

Intensive consolidation therapy compared with standard consolidation and maintenance therapy for adults with acute myeloid leukaemia aged between 46 and 60 years: final results of the randomized phase III study (AML 8B) of the European Organization f

article by Marysia Hengeveld et al published June 2012 in Annals of Hematology

Intensive treatment of patients age 60 years and older with de novo acute myeloid leukemia: analysis of prognostic factors

artículo científico publicado en 1996

Invasive fungal diseases during first induction chemotherapy affect complete remission achievement and long-term survival of patients with acute myeloid leukemia

artículo científico publicado en 2014

Involvement of central nervous system in adult patients with acute myeloid leukemia: Incidence and impact on outcome

scientific article published on 21 February 2018

Lack of prognostic significance of the pretreatment labeling and mitotic indices of marrow blasts in acute nonlymphocytic leukemia (ANLL)

scientific article published on 01 March 1978

Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia

artículo científico publicado en 2005

Liposomal daunorubicin versus standard daunorubicin: long term follow-up of the GIMEMA GSI 103 AMLE randomized trial in patients older than 60 years with acute myelogenous leukaemia

artículo científico publicado en 2008

Long-term observation of 208 adults with chronic idiopathic thrombocytopenic purpura.

artículo científico publicado en 1995

Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab

artículo científico publicado en 2006

Long-term results of all-trans retinoic acid and arsenic trioxide in non-high-risk acute promyelocytic leukemia: update of the APL0406 Italian-German randomized trial

artículo científico publicado en 2019

Longitudinal detection of DNMT3AR882H transcripts in patients with acute myeloid leukemia.

artículo científico publicado en 2018

Low cell concentration of cryopreserved autologous CD34+ peripheral blood progenitor cells does not impair hematopoietic recovery after transplantation

artículo científico publicado en 2003

MACOP-B vs F-MACHOP regimen in the treatment of high-grade non-Hodgkin's lymphomas.

artículo científico publicado en 1995

MEC (mitoxantrone, etoposide and intermediate dose cytarabine): an effective induction regimen for previously untreated acute non-lymphocytic leukemia

scientific article published on 01 November 1995

Management of cancer-related anemia with erythropoietic agents: doubts, certainties, and concerns.

artículo científico publicado en 2005

Mediastinal extramedullary hematopoiesis as first manifestation of hereditary spherocytosis

artículo científico publicado en 1992

Midostaurin in patients with acute myeloid leukemia and FLT3-TKD mutations: a subanalysis from the RATIFY trial

artículo científico publicado en 2020

Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation

artículo científico publicado en 2017

Minimal residual disease as a biomarker for outcome prediction and therapy optimization in acute myeloid leukemia

artículo científico publicado en 2018

Minimal residual disease as biomarker for optimal biologic dosing of ARA-C in patients with acute myeloid leukemia

artículo científico publicado en 2014

Minimal residual disease negativity in elderly patients with acute myeloid leukemia may indicate different postremission strategies than in younger patients

artículo científico publicado en 2015

Minimally differentiated acute myeloid leukemia (AML-M0): a distinct clinico-biologic entity with poor prognosis.

artículo científico publicado en 1996

Molecular analysis of t(15;17) genomic breakpoints in secondary acute promyelocytic leukemia arising after treatment of multiple sclerosis

artículo científico publicado en 2008

Monitoring of minimal residual disease in acute myeloid leukemia

artículo científico publicado en 2009

Monitoring of minimal residual disease in adult acute myeloid leukemia using peripheral blood as an alternative source to bone marrow

scientific article published on 01 May 2007

Multidimensional flow cytometry for detection of minimal residual disease in acute myeloid leukemia.

artículo científico publicado en 2003

Myelodysplastic syndromes in childhood: description of seven cases

artículo científico publicado en 1994

NOTCH1 mutations identify a chronic lymphocytic leukemia patient subset with worse prognosis in the setting of a rituximab-based induction and consolidation treatment.

artículo científico publicado en 2014

Nerve growth factor: a survey of activity on immune and hematopoietic cells

artículo científico publicado en 1999

New reciprocal translocation t(6;10) (q27;q11) associated with idiopathic myelofibrosis and eosinophilia

artículo científico publicado en 2001

Non-infusional vs intravenous consolidation chemotherapy in elderly patients with acute myeloid leukemia: final results of the EORTC-GIMEMA AML-13 randomized phase III trial

scientific article published on 17 August 2006

Novel role of triazenes in haematological malignancies: pilot study of Temozolomide, Lomeguatrib and IL-2 in the chemo-immunotherapy of acute leukaemia

artículo científico publicado en 2007

Novel thrombopoietic agents: a review of their use in idiopathic thrombocytopenic purpura

artículo científico publicado en 2008

O6-(4-bromothenyl)guanine (PaTrin-2), a novel inhibitor of O6-alkylguanine DNA alkyl-transferase, increases the inhibitory activity of temozolomide against human acute leukaemia cells in vitro.

artículo científico publicado en 2006

Once-weekly dosing of recombinant human erythropoietin alpha in patients with myelodysplastic syndromes unresponsive to conventional dosing.

artículo científico publicado en 2004

Opioids in pain management of blood-related malignancies.

artículo científico publicado en 2006

P-glycoprotein and BCL-2 levels predict outcome in adult acute lymphoblastic leukaemia.

artículo científico publicado en 2003

PYRROLO[1,2-b][1,2,5]BENZOTHIADIAZEPINES (PBTDs) induce apoptosis in K562 cells.

artículo científico publicado en 2007

Phase 1/2 study to assess the safety, efficacy, and pharmacokinetics of barasertib (AZD1152) in patients with advanced acute myeloid leukemia

artículo científico publicado en 2011

Placental/umbilical cord blood: experience of st. Eugenio Hospital collection center

scientific article published on 01 July 2005

Positive selection of CD34+ cells by immunoadsorption: factors affecting the final yield and hematopoietic recovery in patients with hematological malignancies and solid tumors

scientific article published on 01 April 2002

Procalcitonin is a reliable marker of severe systemic infection in neutropenic haematological patients with mucositis

scientific article published on 01 May 2010

Prognostic impact of genetic characterization in the GIMEMA LAM99P multicenter study for newly diagnosed acute myeloid leukemia

scientific article published on 27 May 2008

Pulsed intravenous high-dose dexamethasone in adults with chronic idiopathic thrombocytopenic purpura.

artículo científico publicado en 2000

Pyrrolo[1,2-b][1,2,5]benzothiadiazepines (PBTDs) exert their anti-proliferative activity by interfering with Akt-mTOR signaling and bax:bcl-2 ratio modulation in cells from chronic myeloid leukemic patients.

artículo científico publicado en 2010

Pyrrolo[1,2-b][1,2,5]benzothiadiazepines (PBTDs): A New Class of Agents with High Apoptotic Activity in Chronic Myelogenous Leukemia K562 Cells and in Cells from Patients at Onset and Who Were Imatinib-Resistant

article

Pyrrolo[1,2-b][1,2,5]benzothiadiazepines (PBTDs): A New Class of Agents with High Apoptotic Activity in Chronic Myelogenous Leukemia K562 Cells and in Cells from Patients at Onset and Who Were Imatinib-Resistant

Radiotherapy combined with erythropoietin for the treatment of extramedullary hematopoiesis in an alloimmunized patient with thalassemia intermedia

scientific article published on 01 June 1996

Randomized Phase III Trial of Retinoic Acid and Arsenic Trioxide Versus Retinoic Acid and Chemotherapy in Patients With Acute Promyelocytic Leukemia: Health-Related Quality-of-Life Outcomes

artículo científico publicado en 2014

Randomized clinical trial of immunotherapy and androgenotherapy for remission maintenance in acute non-lymphocytic leukemia

artículo científico publicado en 1981

Randomized trial of two schedules of low-dose gemtuzumab ozogamicin as induction monotherapy for newly diagnosed acute myeloid leukaemia in older patients not considered candidates for intensive chemotherapy. A phase II study of the EORTC and [...]

artículo científico publicado en 2010

Relevance of CD49d protein expression as overall survival and progressive disease prognosticator in chronic lymphocytic leukemia

artículo científico publicado en 2007

Response to B-cell depleting therapy with rituximab reverts the abnormalities of T-cell subsets in patients with idiopathic thrombocytopenic purpura

artículo científico publicado en 2007

Retinoic acid and arsenic trioxide for acute promyelocytic leukemia

artículo científico publicado en 2013

Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura.

artículo científico publicado en 2001

Rituximab in the treatment of autoimmune haematological disorders

artículo científico publicado en 2008

Rituximab single agent in age-related Epstein-Barr virus associated B cell disorder complicated by autoimmune anemia and pure red cell aplasia.

artículo científico publicado en 2014

Role of human leukocyte interferon-alpha in the treatment of patients with polycythemia vera

artículo científico publicado en 1998

Secondary acute myeloid leukaemia: results of conventional treatments. Experience of GIMEMA trials

artículo científico publicado en 2005

Selective B-cell depletion with rituximab for the treatment of patients with acquired hemophilia.

artículo científico publicado en 2004

Sequential combination chemotherapy of high-grade non-Hodgkin's lymphoma with 5-fluorouracil, methotrexate, cytosine-arabinoside, cyclophosphamide, doxorubicin, vincristine, and prednisone (F-MACHOP)

scientific article published on 01 January 1987

Sequential combination of gemtuzumab ozogamicin and standard chemotherapy in older patients with newly diagnosed acute myeloid leukemia: results of a randomized phase III trial by the EORTC and GIMEMA consortium (AML-17).

artículo científico publicado en 2013

Sequential combination of high dose ARA-C (HiDAC) and asparaginase (ASP) for the treatment of advanced acute leukemia and lymphoma

artículo científico publicado en 1984

Sequential valproic acid/all-trans retinoic acid treatment reprograms differentiation in refractory and high-risk acute myeloid leukemia

scientific article published on 01 September 2006

Severe autoimmune hemolytic anemia in a patient with chronic lymphocytic leukemia responsive to fludarabine-based treatment

artículo científico publicado en 1992

Short term treatment with Escherichia coli recombinant human granulocyte-macrophage-colony stimulating factor prior to chemotherapy for Hodgkin disease

artículo científico publicado en 2000

Should rituximab be used before or after splenectomy in patients with immune thrombocytopenic purpura?

artículo científico publicado en 2007

Simultaneous detection of NPM1 and FLT3-ITD mutations by capillary electrophoresis in acute myeloid leukemia.

artículo científico publicado en 2005

Simultaneous occurrence of BCR/ABL1 and RUNX1/RUNX1T1 in a case of therapy-related acute myeloid leukemia

artículo científico publicado en 2009

Specific scoring systems to predict survival of patients with high-risk myelodysplastic syndrome (MDS) and de novo acute myeloid leukemia (AML) after intensive antileukemic treatment based on results of the EORTC-GIMEMA AML-10 and intergroup CRIANT

artículo científico publicado en 2014

Sphingosine kinase 1 overexpression is regulated by signaling through PI3K, AKT2, and mTOR in imatinib-resistant chronic myeloid leukemia cells.

artículo científico publicado en 2011

Spontaneous apoptosis and proliferation detected by BCL-2 and CD71 proteins are important progression indicators within ZAP-70 negative chronic lymphocytic leukemia.

artículo científico publicado en 2010

Subcutaneous administration of interleukin-2 triggers Fcgamma receptor I expression on human peripheral blood neutrophils in solid and hematologic malignancies.

artículo científico publicado en 2001

Successful pregnancy after arsenic trioxide therapy for relapsed acute promyelocytic leukaemia

Successful treatment of disseminated fusariosis with high dose liposomal amphotericin-B in a patient with acute lymphoblastic leukemia

artículo científico publicado en 2005

Sustained response to recombinant human erythropoietin and intermittent all-trans retinoic acid in patients with myelodysplastic syndromes

artículo científico publicado en 2002

Temsirolimus, an mTOR inhibitor, in combination with lower-dose clofarabine as salvage therapy for older patients with acute myeloid leukaemia: results of a phase II GIMEMA study (AML-1107)

artículo científico publicado en 2011

The addition of rituximab to fludarabine improves clinical outcome in untreated patients with ZAP-70-negative chronic lymphocytic leukemia

artículo científico publicado en 2005

The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura

artículo científico publicado en 2004

The genotype nucleophosmin mutated and FLT3-ITD negative is characterized by high bax/bcl-2 ratio and favourable outcome in acute myeloid leukaemia.

artículo científico publicado en 2010

The kinetics of reduction of minimal residual disease impacts on duration of response and survival of patients with acute myeloid leukemia

artículo científico publicado en 2006

The role of angiogenesis in hematologic malignancies

artículo científico publicado en 2002

The stem cell mobilizing capacity of patients with acute myeloid leukemia in complete remission correlates with relapse risk: results of the EORTC-GIMEMA AML-10 trial

artículo científico publicado en 2003

Thoracic cord compression caused by epidural extramedullary hematopoiesis during erythroid-stimulating agent therapy in two patients with myelodysplastic syndromes

artículo científico publicado en 2013

Toward optimization of postremission therapy for residual disease-positive patients with acute myeloid leukemia.

artículo científico publicado en 2008

Treatment of Low-Blast Count AML using Hypomethylating Agents

artículo científico publicado en 2017

Treatment of MOPP-resistant Hodgkin's disease with adriamycin, bleomycin, vinblastine and dacarbazine (ABVD).

artículo científico publicado en 1982

Treatment of adult acute lymphoblastic leukemia (ALL): long-term follow-up of the GIMEMA ALL 0288 randomized study

artículo científico publicado en 2002

Treatment of elderly patients (> or =60 years) with newly diagnosed acute promyelocytic leukemia. Results of the Italian multicenter group GIMEMA with ATRA and idarubicin (AIDA) protocols.

artículo científico publicado en 2003

Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia: final results of AML-13, a randomized phase-3 study

artículo científico publicado en 2005

Valproic acid at therapeutic plasma levels may increase 5-azacytidine efficacy in higher risk myelodysplastic syndromes.

artículo científico publicado en 2009

Variable patterns of response to rituximab treatment in adults with chronic idiopathic thrombocytopenic purpura

scientific article published on 01 May 2002

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda